Daniel Dicapua, MD
Neurology · New Haven, CTNPI 1134301179
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Argenx US, Inc. accounts for 81.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $31,390 and has fallen 87.8% since, to $3,817 in 2025. Among neurology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $860.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Argenx US, Inc.$69K
- CSL Behring$8K
- AstraZeneca$4K
- Grifols USA, LLC$3K
What the payments were for
- Consulting fees$15,75018%
- Speaking & faculty fees$50,64059%
- Travel & lodging$16,47019%
- Food & beverage$2,3123%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Argenx US, Inc. | 75 | $69,362 |
| CSL Behring | 8 | $8,154 |
| AstraZeneca | 13 | $4,342 |
| Grifols USA, LLC | 3 | $3,314 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$85,173 in reported general payments places this provider in the 90th percentile of 280 neurology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 58 | $1,185,931 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 65 | $887,973 |
| EvrysdiRisdiplam | 30 | $805,702 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 18 | $235,031 |
| KeveyisDichlorphenamide | 12 | $68,236 |
| Gabapentin | 176 | $5,065 |
| Pregabalin | 156 | $3,920 |
| Baclofen | 85 | $1,844 |
| Duloxetine Hcl | 51 | $1,409 |
| Mycophenolate Mofetil | 15 | $1,287 |
| Pyridostigmine Bromide | 28 | $1,205 |
| Azathioprine | 17 | $636 |
| Prednisone | 53 | $569 |
| Tizanidine Hcl | 40 | $538 |
| Tramadol Hcl | 18 | $284 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Grifols USA, LLCGamunex-C | $3,314 | $1,185,93158 claims |
| CSL BehringPrivigen | $8,154 | $887,97365 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 280 neurology providers in Connecticut.
Other neurology in New Haven
- Sharon StollNew Haven$822K
- Mary BaileyNew Haven$630K
- Stephen WaxmanNew Haven$252K
- Ariel LeflandNew Haven$220K
- David RussellNew Haven$208K
- Richard NowakNew Haven$126K
- David HaflerNew Haven$118K
- Kenneth MarekNew Haven$86K
- Lee SchwammNew Haven$55K
- Marcelo MatielloNew Haven$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.